Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessAccuracy of preliminary remission criteria some JIA category
-
Article
Open AccessRelationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis
-
Article
Open AccessChronic Recurrent Multifocal Osteomyelitis (CRMO): four cases treated with aminobisphosphonate (pamidronate)
-
Article
Open AccessAnakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
-
Article
Open AccessEfficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
-
Article
Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients
In this study we aimed at evaluating the modifications in the pharmacokinetic profile of cyclosporin A (CyA) after conversion from standard formulation (CyA-ST) to a new formulation (CyA-NF, Sandimmun Neoral)...
-
Article
Bf polymorphism and juvenile rheumatoid arthritis
-
Article
Mediterranean Symposium of rheumatology